Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The company’s shares closed yesterday at $11.94.

Don’t sleep on the importance of a good, clean, tacky golf grip. It can make a world of difference and make your grips last even longer, meaning you can save money without having to replace them.

10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating restated by equities researchers at Weiss Ratings in a note issued to investors on Friday,Weiss Ratings reports.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa ...

10x Genomics (NASDAQ:TXG – Free Report) had its price objective trimmed by JPMorgan Chase & Co. from $14.00 to $12.00 in a research note issued to investors on Thursday morning,Benzinga reports.

Fortunately, I've found the perfect base product to help me solve this problem without compromising on coverage: Milk Makeup's Hydro Grip Gel Skin Tint ($36). As someone with sensitive skin ...

Citi lowered the firm’s price target on 10x Genomics (TXG) to $15 from $20 and keeps a Buy rating on the shares. The firm updated models in the life science tools and diagnostics group post the ...

Torex Gold Resources Inc. operates as an intermediate gold producer. The company engages in the exploration, development, and operation of principal asset comprising 100% owned the Morelos Gold ...

Although Call of Duty: Warzone often involves long-range engagements, there are many situations where close-quarters combat is unavoidable. To increase your chances of winning these fights ...

To further enhance handling with improved aim-down-sight and sprint-to-fire speeds, the Commando Grip is highly effective. Lastly, finishing with the Compensator helps control the GS45's vertical ...